Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy

Journal of Molecular Medicine

Volumn 75, Issue 8, 1997, Pages 594-602

  Springer, Georg F ^a,b,c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Efficacious carcinoma vaccine; Erythrocyte derived T Tn antigen; Immune responses to T and Tn antigens; Preclinical carcinoma detection by T assays; T Tn epitopes in carcinoma pathogenesis; T Tn epitopes in cell adhesion and delayed type hypersensitivity skin reactions; T Tn pancarcinoma autoimmunogens

Indexed keywords

EPITOPE; GLYCOPROTEIN; TUMOR ANTIGEN; TUMOR VACCINE;

BLOOD GROUP O; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CELLULAR IMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOREACTIVITY; METASTASIS; PROGNOSIS; REVIEW; VACCINATION;

EID: 0030848719     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050144     Document Type: Review

References (74)

1. Springer GF, Ansell NJ (1958) Inactivation of human erythrocyte agglutinogens M and N by influenza viruses and receptor-destroying enzyme. Proc Natl Acad Sci USA 44:182-189
2. Springer GF, Desai PR, Schachter H, Narusimhan S (1976) Enzymatic synthesis of human blood group M-, N- and T-specific structures. Naturwissenschaften 63:488-489
3. Desai PR, Springer GF (1979) Biosynthesis of blood group T-, N-, and M-specific immunodeterminants on human erythrocyte antigens. J Immunogenet 6:403-417
4. Springer GF (1984) T and Tn general carcinoma autoantigens. Science 224:1198-1206
5. b substances. Proc Natl Acad Sci USA 61:1470-1477
6. Donald ASR, Creeth JM, Morgan WTJ, Watkins WM (1969) The peptide moiety of human blood group active glycoproteins associated with the ABO and Lewis groups. Biochem J 115:125-127
7. Springer GF, Desai PR, Banatwala I (1975) Blood group MN antigens and precursors in normal and malignant human breast glandular tissue. J Natl Cancer Inst 54:335-339
8. Springer GF, Desai PR, Murthy MS, Tegtmeyer H, Scanlon EF (1979) Human carcinoma-associated precursor antigens of the blood group MN system and the host's immune responses to them. Prog Allergy 26:42-96
9. Anglin JH Jr, Luner MP, Nordquist RE (1977) Blood group-like activity released by human mammary carcinoma cells in culture. Nature 269:254-255
10. Laurent JC, Noël P, Faucon M (1978) Expression of a cryptic cell surface antigen in primary cell cultures from human breast cancer. Biomedicine 29:260-261
11. Coon JS, Weinstein RS, Summers JL (1982) Blood group precursor T-antigen expression in human urinary bladder carcinoma. Am J Clin Pathol 77:692-699
12. Bray J, Maclean GD, Dusel FJ, McPherson TA (1982) Decreased levels of circulating lytic anti-T in the serum of patients with metastatic gastrointestinal cancer: a correlation with disease burden. Clin Exp Immunol 47:176-182
13. Springer GF, Desai PR (1974) Common precursors of human blood group MN specificities. Biochem Biophy Res Commun 61:470-475
14. Springer GF, Desai PR, Scanlon EF (1976) Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them. Cancer 37:169-176
15. Springer GF, Nagai Y, Tegtmeyer H (1966) Isolation and properties of human blood-group NN and meconium-Vg antigens. Biochemistry 5:3254-3272
16. Springer GF, Tegtmeyer H (1981) Origin of anti-Thomsen-Friedenreich (T) and Tn agglutinins in man and in White Leghorn chicks. Br J Haematol 47:453-460
17. Metcalfe SM, Springer GF, Svvennsen RJ, Tegtmeyer H (1984) Monoclonal antibodies specific for human Thomsen-Friedenreich (T) and Tn blood group precursor antigens. Protides Biol Fluids Proc 32:765-768
18. Stein R, Chen S, Grossman W, Goldenberg DM (1989) A human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen. Cancer Res 49:32-37
19. Springer GF, Chandrasekaran EV, Desai PR, Tegtmeyer H (1988) Blood group Tn-active macromolecules from human carcinomas and erythrocytes: characterization of and specific reactivity with mono- and poly-clonal anti-Tn antibodies induced by various immunogens. Carbohydr Res 178:271-292
20. Hirohashi S, Clausen H, Yamada T, Shimosato Y, Hakomori S-I (1985) Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in carcinoma of blood group O or B individuals: its identification as Tn antigen. Proc Natl Acad Sci USA 82:7039-7043
21. Roxby DJ, Skinner JM, Morley AA, Weeks S, Burpee M (1987) Expression of a Tn-like epitope by carcinoma cells. Br J Cancer 56:734-737
22. Wang B-L, Springer GF, Carlstedt SC (1997) Quantitative image analysis of Tn and T (Thomsen-Friedenreich) epitopes in prognostication of human breast carcinoma (submitted)
23. Springer GF, Taylor CR, Howard DR, Tegtmeyer H, Desai PR, Murthy SM, Felder B, Scanlon EF (1985) Tn, a carcinoma-associated antigen, reacts with anti-Tn of normal human sera. Cancer 55:561-569
24. Turner DT, Connolly CE, Isaacson P, Turnbull AR (1978) Receptors for Fc and complement in human breast carcinoma. Clin Oncol 4:87-92
25. Black MM, Speer FD (1959) Immunology of cancer. Int Abstr Surg 109:105-116
26. Springer GF, Murthy MS, Desai PR, Scanlon EF (1980) Breast cancer patient's cell-mediated immune response to Thomsen-Friedenreich (T) antigen. Cancer 45:2949-2954
27. Springer GF, Desai PR, Wise W, Carlstedt, SC, Tegtmeyer H, Stein R, Scanlon EF (1990) Pancarcinoma T and Tn epitopes: autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis. In: Herberman RB, Mercer DW (eds) Immunodiagnosis of cancer, 2nd edn. Dekker, New York, pp 587-612
28. Thomson DMP, Springer GF, Desai PR, Scanzano R, Gubersky M, Shenouda G (1988) Comparison by leukocyte adherence inhibition of human immune response to cancer-associated immunogens, Thomsen-Friedenreich (T) and Tn, myelin basic protein, and organ-specific cancer neoantigens. Clin Immunol Immunopathol 49:231-241
29. Ichinose Y, Yagawa K, Kaku M, Hara N, Ohta M (1985) Immune reactivity to Thomsen-Friedenreich antigen in patients with lung cancer detected by superoxide assay-leukocyte adherence inhibition test. Cancer Res 45:4473-4477
30. Black MM, Zachrau RE, Hankey BF, Feuer E (1996) Prognostic significance of in situ carcinoma associated with invasive breast carcinoma. A natural experiment in cancer immunology. Cancer 78:778-788
31. Springer GF (1995) T & Tn pancarcinoma markers: autoantigenic adhesion molecules in pathogenesis, prebiopsy carcinoma-detection and long-term breast carcinoma immuno-therapy. Crit Rev Oncogen 6:57-85
32. Lind PE, McArthur NR (1947) The distribution of "T" agglutinins in human sera. Aust J Exp Biol Med Sci 25:247-250
33. Springer GF, Desai PR, Ghazizadeh M, Tegtmeyer H (1995) T/Tn pancarcinoma autoantigens: fundamental, diagnostic, and prognostic aspects. Cancer Detect Prev 19:173-182
34. Schneider AW, Fischer K, Stegner HE, Poschmann A (1986) Automatic determination of anti-T antibodies in patients with breast carcinoma and controls. Tumor Diagn Ther 7:78-84
35. Thatcher N, Hashmi K, Chang J, Swindell R, Crowther D (1980) Anti-T antibody in malignant melanoma patients. Influence of response and survival following chemotherapy - changes in serum levels following C parvum, BCG immunization. Cancer 46:1378-1382
36. Vos GH, Rose EF, Vos D (1981) Antibody responses to T-activated red cells in children from high- and low-risk areas of cancer of the oesophagus in Transkei. S Afr Med J 59:56-60
37. Desai PR, Ujjainwala LH, Carlstedt SC, Springer GF (1995) Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection. J Immunol Meth 188:175-185
38. Springer GF, Desai PR, Tegtmeyer H, Spencer BD, Scanlon EF (1993) Pancarcinoma T/Tn antigen detects human carcinoma long before biopsy does and its vaccine prevents breast carcinoma recurrence. Ann NY Acad Sci 690: 355-357
39. Suzuki N, Yamamoto K, Toyoshima S, Osawa T, Irimura T (1996) Molecular cloning and expression of cDNA encoding human macrophage C-type lectin. Its unique binding specificty for Tn antigen. J Immunol 156:128-135
40. Schlepper-Schäfer J, Springer G, Holl N, Kolb H, Kolb-Bachofen V (1987) Macrophages from rat liver bind breast carcinoma cells and ingest tumor associated T and Tn antigens, Immunobiol Suppl 3:180
41. Schlepper-Schäfer J, Springer GF (1989) Carcinoma autoantigens T and Tn and their cleavage products interact with Gal/GalNAc-specific receptors on rat Kupffer cells and hepatocytes. Biochim Biophys Acta 89:266-272
42. Springer GF, Cheingsong-Popov R, Schirrmacher V, Desai PR, Tegtmeyer H (1983) Proposed molecular basis of murine tumor cell-hepatocyte interaction. J Biol Chem 258:5702-5706
43. Coon JS, McCall A, Miller AW, Farrow GM, Weinstein RS (1985) Expression of blood group-related antigens in carcinoma in situ of the urinary bladder. Cancer 56:797-804
44. Seitz RC, Fischer K, Stegner HE, Poschmann A (1984) Detection of metastatic breastcarcinoma cells by immunofluorescent demonstration of Thomsen-Friedenreich antigen. Cancer 54: 830-836
45. Cao Y, Karsten U, Liebrich W, Haensch W, Springer GF, Schlag P (1995) Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas: a reevaluation. Cancer 76:1700-1708
46. Zebda N, Bailly M, Brown S, Doré JF, Berthier-Vergnes O (1994) Expression of PNA-binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential. J Cell Biochem 54:161-173
47. Namada S, Furumoto H, Kamada M, Hirao T, Aono T (1993) High expression rate of Tn antigen in metastatic lesions of uterine cervical cancer. Cancer Lett 74:167-173
48. Hirao T, Sakamoto Y, Kamada M, Hamada S-I, Aono T (1993) Tn antigen, a marker of potential for metastasis of uterine cervix cancer cells. Cancer 72:154-159
49. Springer GF, Desai PR, Tegtmeyer H, Carlstedt SC, Scanlon EF (1994) T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced human breast carcinoma. Cancer Biotherapy 9:7-15
50. Springer GF, Desai PR, Spencer BD, Tegtmeyer H, Carlstedt SC, Scanlon EF (1995) T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced breast carcinoma. Cancer Detect Prev 19:374-380
51. Springer GF (1997) T/Tn antigen: 2 decades of experience in early immuno-detection and -therapy of human carcinoma. In: Siegenthaler W, Haas R (eds) Jung-Stiftung für Wissenschaft und Forschung. Thieme, Stuttgart, pp 25-31
52. Cohen J (1993) Cancer vaccines get a shot in the arm. Science 262:841-843
53. Mitchell MS, Kan-Mitchell J, Kempf RA, Harel W, Shau H, Lind S (1988) Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant. Cancer Res 48:5883-5893
54. Hareuveni M, Gautier C, Kieny M-P, Wreschner D, Chambon P, Lathe R (1990) Vaccination against tumor cells expressing breast cancer epithelial tumor antigen. Proc Natl Acad Sci USA 87:9498-9502
55. Maclean GD, Bowen-Yacyshyn MB, Samuel J, Meikle A, Stuart G, Nation J, Poppema S, Jerry M, Koganty R, Wong T, Longenecker BM (1992) Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen. J Immunotherapy 11:292-305
56. Taylor-Papadimitriou J, Epenetos AA (1994) Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy. TIBTECH 12:227-233
57. Kündig TM, Bachmann MF, Oehen S, Hoffmann UW, Simard JJL, Kalberer CP, Pircher H, Ohashi PS, Hengartner H, Zinkernagel RM (1996) On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci USA 93:9716-9723
58. Gloeckler-Ries LA, Henson DE, Harras A (1994) Survival from breast cancer according to tumor size and nodal status. Surg Oncol Clinics North Am 3:35-53.
59. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zähringer U, Seydel U, DiPadova F, Schreier M, Brade H (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8:217-225
60. Springer GF (1989) Tn epitope (N-acetyl-D-galactosamine α-O-serine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness. Mol Immunol 26:1-5
61. Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature 256:495-497
62. Heidelberger M, Goebel WF, Avery OT (1925) The soluble specific substance of a strain of Friedländer's bacillus. Exp Med 43:701-707
63. Goebel WF (1939) Studies on antibacterial immunity induced by artificial antigens. I. Immunity to experimental pneumococcal infection with an antigen containing cellobiuronic acid. J Exp Med 69:353-364
64. Edelman GM, Crossin KL (1991) Cell adhesion molecules: Implications for a molecular histology. Ann Rev Biochem 60:155-190
65. Devine PL, McKenzie IFC (1992) Mucins: structure, function, and associations with malignancy. Bioessays 14:619-624
66. Fukuda M (1996) Possible roles of tumor-associated carbohydrate antigens. Cancer Res 56:2237-2244
67. Edelman G, Rutishauser Y (1981) Molecules involved in cell adhesion. J Supramol Struct Cell Biochem 16:259-268
68. Hakomori S-I (1996) Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56:5309-5318
69. Hilkens J, Ligtenberg MJL, Vos HL, Litvinov SV (1992) Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci 17:359-363
70. Ehrlich P (1909) Ueber den jetzigen Stand der Karzinomforschung. Ned T Geneesk 5: 274-290
71. e Conference internationale pour l'étude du cancer. Alcan, Paris, 753-758
72. Peters KP, Fauck J, Frömmel C (1996) The automatic search for ligand binding sites in proteins of known three-dimensional structure using only geometric criteria. J Mol Biol 256:2101-213
73. Tomita M, Marchesi VT (1975) Amino-acid sequence and oligosaccharide attachment sites of human erythrocyte glycophorin. Proc Natl Acad Sci USA 72:2964-2968
74. 2-terminal sialoglycopentapeptide from human blood group MM red cells. Naturwissenschaften 65:547